Cornerstone Advisors, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cornerstone Advisors, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,0000.0%36
+50.0%
0.00%
Q2 2020$1,0000.0%24
-31.4%
0.00%
Q1 2020$1,000
-96.3%
35
-95.7%
0.00%
-100.0%
Q2 2019$27,000
+3.8%
813
+10.0%
0.00%0.0%
Q1 2019$26,000
+4.0%
739
-1.9%
0.00%
-25.0%
Q4 2018$25,000
-34.2%
7530.0%0.00%
-84.0%
Q3 2018$38,000
-15.6%
7530.0%0.02%
-19.4%
Q2 2018$45,000
+32.4%
7530.0%0.03%
+34.8%
Q1 2018$34,000
+17.2%
753
+1.9%
0.02%
+21.1%
Q4 2017$29,000
-3.3%
7390.0%0.02%
-9.5%
Q3 2017$30,000
-31.8%
739
-28.3%
0.02%
-16.0%
Q2 2017$44,000
+37.5%
1,0310.0%0.02%
+38.9%
Q1 2017$32,000
+23.1%
1,0310.0%0.02%
-18.2%
Q4 2016$26,000
+4.0%
1,0310.0%0.02%
+4.8%
Q3 2016$25,000
+19.0%
1,0310.0%0.02%0.0%
Q2 2016$21,000
+31.2%
1,0310.0%0.02%
+23.5%
Q1 2016$16,000
+14.3%
1,0310.0%0.02%
+13.3%
Q4 2015$14,0000.0%1,0310.0%0.02%
+25.0%
Q3 2015$14,0001,0310.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders